Research of heat shock protein 47 and defensins in the pathogenesis of pulmonary fibrosis
热休克蛋白47和防御素在肺纤维化发病机制中的研究
基本信息
- 批准号:17590795
- 负责人:
- 金额:$ 1.86万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Heat shock Protein (HSP) 47 is involved in the synthesis/assembly of various collagens as a collagen-Specific molecular chaperone. HSP 47 expression has been shown upregulated in liver cirrhosis and other fibrotic diseases. We have studied the effect of α-defensin, cationic proteins with antimicrobial and cytotoxic activity in the azurophil granule of neutrophils, on the production of HSP 47 and collagen using lung fibroblasts, and the relationship between HSP47 expression and fibrotic process in murine bleomycin-induced pulmonary fibrosis. At first, using surgical biopsy specimens from human patients, we demonstrated that expression of HSP47 in lung fibroblasts and type II pneumocytes was significantly higher in idiopathic usual interstitial pneumonia (UIP) patients than in those with collagen vascular disease-associated UIP and idiopathic non-specific interstitial pneumonia, which has the better prognosis compared with idiopathic UIP. We also investigated the direct effect of α-defen … More sin (human neutrophil peptide (HNP)-1) on expression of HSP47 and collagen-1 in human lung fibroblasts. HNP-1 5 μg/ml induced fibroblast proliferatioh and concentrations >50 μg/ml of HNP-1 reduced the cell-viability. Expression of HSP 47 and collagen-1 mRNA was significantly increased by 10 to 25 μg/ml of HNP-1, whereas their protein release increased in dose-dependent manner. TGF-beta also enhanced the expression of these mRNA and proteins in human normal fibroblasts and A549 cells, and pirfenidone inhibited these findings. In addition, We are studying the effects of TGF-beta on expression of growth factors including PDGF and HGF in A549 and fibroblasts using real time PCR. In murine bleomycin-induced pulmonary fibrosis, a good correlation was also observed between the degree of pulmonary fibrosis and expression of HSP47 using in situ hybridization. Our results suggest that α-defensin may promote directly fibrotic process through upregulation of HSP 47 and collagen-1 in human lung fibroblasts and play an important role in the pathogenesis of pulmonary fibrosis and HSP47 positive cells may have an ability of enhanced collagen synthesis and release. Pirfenidone inhibited directly these positive cells responsible for the accumulation and deposition of extracellular matrix seen in pulmonary fibrosis. These findings suggest that BSP47 and α-defensin might be anew promising target for the treatment of idiopathic pulmonary fibrosis. Less
热休克蛋白(HSP) 47作为一种胶原特异性分子伴侣参与多种胶原的合成/组装。hsp47在肝硬化和其他纤维化疾病中表达上调。我们研究了中性粒细胞azurophil颗粒中具有抗菌和细胞毒活性的阳离子蛋白α-防御素(α-defensin)对肺成纤维细胞产生HSP47和胶原蛋白的影响,以及在博莱霉素诱导的小鼠肺纤维化中HSP47表达与纤维化过程的关系。首先,我们利用人类患者的手术活检标本,证实了特发性通常间质性肺炎(UIP)患者肺成纤维细胞和II型肺细胞中HSP47的表达明显高于胶原血管病相关的UIP和特发性非特异性间质性肺炎,与特发性UIP相比,其预后更好。我们还研究了α- defend . More sin (human neutropil peptide, HNP)-1)对人肺成纤维细胞HSP47和胶原-1表达的影响。5 μg/ml的HNP-1可诱导成纤维细胞增殖,50 μg/ml的HNP-1可降低成纤维细胞活力。10 ~ 25 μg/ml的HNP-1可显著提高hsp47和collagen-1 mRNA的表达,并使其蛋白释放量呈剂量依赖性增加。tgf - β也增强了这些mRNA和蛋白在人正常成纤维细胞和A549细胞中的表达,而吡非尼酮抑制了这些发现。此外,我们正在使用real - time PCR技术研究tgf - β对A549和成纤维细胞中PDGF和HGF等生长因子表达的影响。在博莱霉素诱导的小鼠肺纤维化中,原位杂交也观察到肺纤维化程度与HSP47的表达有良好的相关性。我们的研究结果提示α-防御素可能通过上调人肺成纤维细胞中HSP47和胶原-1直接促进纤维化过程,在肺纤维化的发病机制中发挥重要作用,HSP47阳性细胞可能具有增强胶原合成和释放的能力。吡非尼酮直接抑制肺纤维化中细胞外基质积累和沉积的阳性细胞。这些发现提示BSP47和α-防御素可能是治疗特发性肺纤维化的新靶点。少
项目成果
期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia
- DOI:10.1183/09031936.06.00105904
- 发表时间:2006-02-01
- 期刊:
- 影响因子:24.3
- 作者:Ishimoto, H;Mukae, H;Nakazato, M
- 通讯作者:Nakazato, M
The expression of pro- and anti-apoptotic Bcl-2 family proteins in peribronchiolar lymphocytes from patients with diffuse panbronchiolitis.
弥漫性全细支气管炎患者细支气管周围淋巴细胞中促凋亡和抗凋亡 Bcl-2 家族蛋白的表达。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Kadota J;Mizunoe S;et al.
- 通讯作者:et al.
Elevated levels of serum and bronchoalveolar lavage fluid concentrations of antimicrobial peptides in patients with interstitial lung diseases
间质性肺疾病患者血清和支气管肺泡灌洗液中抗菌肽浓度升高
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:Mukae H;et al.
- 通讯作者:et al.
Different effects of clarithromycin and azithromycin on productions of cytokines by murine dendritic cells
克拉霉素和阿奇霉素对小鼠树突状细胞产生细胞因子的不同影响
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Sugiyama K;Shirai R;Mukae H;et al.
- 通讯作者:et al.
Differential effects of α- and β-defensin on cytokine production by cultured human bronchial epithelial cells
- DOI:10.1152/ajplung.00076.2004
- 发表时间:2005-03-01
- 期刊:
- 影响因子:4.9
- 作者:Sakamoto, N;Mukae, H;Kohno, S
- 通讯作者:Kohno, S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MUKAE Hiroshi其他文献
MUKAE Hiroshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MUKAE Hiroshi', 18)}}的其他基金
Autoantibodies in idiopathic interstitial pneumonias
特发性间质性肺炎中的自身抗体
- 批准号:
17K09617 - 财政年份:2017
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Fundamental study of development of new antibiotics using defensins
利用防御素开发新型抗生素的基础研究
- 批准号:
20590927 - 财政年份:2008
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research of heat shock protein 47 in lung fibtotic process
热休克蛋白47在肺纤维化过程中的研究
- 批准号:
15590817 - 财政年份:2003
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research of defensins in respiratory infection
呼吸道感染中防御素的研究
- 批准号:
13670607 - 财政年份:2001
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Mechanochemical interplay between Extracellular Matrix and cellular responses in Idiopathic Pulmonary Fibrosis (Ref: 4659)
特发性肺纤维化中细胞外基质和细胞反应之间的机械化学相互作用(参考文献:4659)
- 批准号:
2885583 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Studentship
Development of a Palliative Care Model based on Dignity-Centered Care for Patients with Idiopathic Pulmonary Fibrosis
开发基于以尊严为中心的特发性肺纤维化患者姑息治疗模式
- 批准号:
23K16423 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
The role of cellular senescence of vascular endothelial cells in idiopathic pulmonary fibrosis and complicated pulmonary hypertension.
血管内皮细胞衰老在特发性肺纤维化和复杂性肺动脉高压中的作用。
- 批准号:
23K15189 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a targeted TGF-b therapeutic that selectively blocks lung fibrosis in idiopathic pulmonary fibrosis (IPF) patients
开发选择性阻断特发性肺纤维化 (IPF) 患者肺纤维化的靶向 TGF-b 疗法
- 批准号:
10697961 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Development of BIO 300 as a novel treatment for idiopathic pulmonary fibrosis
BIO 300 的开发作为特发性肺纤维化的新型治疗方法
- 批准号:
10603367 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)
IL-17A mRNA 靶向寡核苷酸治疗特发性肺纤维化 (IPF)
- 批准号:
10761365 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Development of sialidase inhibitors for treatment of idiopathic pulmonary fibrosis
开发治疗特发性肺纤维化的唾液酸酶抑制剂
- 批准号:
23K05054 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Corticosteroids for Acute Exacerbations of Idiopathic Pulmonary Fibrosis: Patterns and Outcomes
皮质类固醇治疗特发性肺纤维化急性加重:模式和结果
- 批准号:
10679224 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Proteomic Profiling of Idiopathic Pulmonary Fibrosis Progression Trajectory
特发性肺纤维化进展轨迹的蛋白质组学分析
- 批准号:
10708256 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别: